发布时间:2019-05-20 19:39 原文链接: ExtractionofRNAfromFrozenSections

RNA Extraction from Frozen Tissue Sections

 

Tissue Handling: Note that all unfixed human tissue should be handled as BioSafety Level 2 materials (wear gloves, lab coat, etc). All plasticware (tubes, tips, etc.) should be RNase free and always handled with gloves to avoid contamination of the sample with RNases. In general, it is not necessary to treat plastic ware to eliminate RNase contamination- just keep separate, unopened stocks of tubes and tips for autoclaving that are always handled while wearing gloves. Similarly, all chemicals used for RNA should be dedicated for that purpose and handled with gloves to avoid contamination.

 

1.      Prepare a scintillation vial (Fisher #3-341-13) for each sample containing 1.5 ml of Trizol (Invitrogen#15596-026). Exercise proper laboratory practice when handling Trizol, as it is toxic and corrosive (i.e., wear gloves, lab coat, eye protection). Also label a 14 ml round bottomed polypropylene centrifuge tube (Falcon #2059) for each sample.

 

2.      In a cryostat at -20°C, cut the desired number of sections and place in the scintillation vial containing Trizol. The scintillation vial is used because the large opening allows the sections to be placed directly in Trizol to prevent degradation of the RNA and sticking of the sections to the sides of the tube. The number of sections to be cut can be estimated as follows:

 

Pre-cut a thin section (5 mm) and H&E stain it to determine if the sample contains sufficient tumor cells (we prefer at least 70% tumor cells). Measure the length and width of the section. The number of sections needed is then estimated as follows:

 

Length (mm) ´ width (mm) ´ thickness of sections (mm) ´ # sections = X

where X has a value between  and 20 and 100 mm3

 

For example, a 4´5 mm section would require a minimum of 20 50mm sections (4´5´0.05´20= 20 mm3)

 

Sometimes it is not possible to cut the minimum number of sections to meet the above criteria. If this is the case, cut as many sections as possible making sure to leave enough tissue to take an “AFTER” section for H&E staining to verify the tumor cell content.

 

3.      Homogenize the tissue for 30 seconds in the scintillation vial so that no large pieces of tissue are evident. Perform the homogenization in a Biosafety cabinet to avoid exposure to aerosolized tissue, with the vial in a beaker filled with ice to keep the sample cold.

 

4.      Transfer the homogenate to the Falcon 2059 tube that is in an ice bucket. Rinse the scintillation vial out with 0.5 mL of Trizol in order to get any residual tissue and add to the Falcon tube. Dispose of the scintillation vial in chemical waste.

 

5.      Homogenize for 2 minutes, keeping the tube in a small beaker filled with ice to prevent overheating. Homogenization in this tube gives a smaller surface area, allowing more efficient homogenization. Once homogenized, the tissue can be stored at -80°C for at least one month prior to extraction.

 

6.       Transfer the Trizol to two 1.5ml microfuge tubes (1 ml in each).

 

7.      Add 200 ml of chloroform for each ml of Trizol.

 

8.      Vortex for ~10 seconds to mix the Trizol-chloroform.

 

9.      Spin at 12,000´g at 4°C for 15 minutes in a microfuge.

 

10.  Transfer the clear aqueous upper phase to a fresh microfuge tube, being careful to avoid the white interphase, which contains DNA and proteins. The remaining Trizol can be saved for extraction of DNA or disposed of in chemical waste.

 

11.  Add 2.5 ml of 5mg/ml linear acrylamide (Ambion #9250) to the extracted aqueous solution (final working concentration should be in the 10-20 mg/ml range). Linear acrylamide acts as a coprecipitant to aid in precipitating small amounts of RNA. Alternatively, glycogen can be used as a coprecipitant (final working concentration of 50-150 mg/ml- available from Ambion as 5mg/ml #9510).

 

12.  Add 0.9 vol of isopropanol (typically 540 ml of isopropanol added to 600 ml of aqueous solution).

 

13.  Precipitate RNA for at least 1 hour (up to overnight) in a -20°C freezer.

 

14.  Pellet the RNA by spinning at 12,000´g at 4°C for 15 minutes in a microfuge.

 

15.  Remove supernatant and rinse with 500 ml of ice cold 70% ethanol.

 

16.  Spin down in microfuge at 7,500´g at 4°C for 5 minutes.

 

17.  Quickly remove supernatant. Failure to remove the 70% ethanol quickly can result in breakup of the pellet and potential loss of RNA while removing the supernatant. Respin the tube as in step 17 if you see evidence of the pellet fragmenting.

 

18.  Air-dry the pellet. Since there are two tubes, it is a good idea to dissolve one pellet in formamide for long-term storage, and the other in nuclease free water for immediate use. Typically we dissolve the RNA from sections in 30-50 ml of water or formamide. When the pellet dries, it will become clear (it will be white in color prior to this). When using formamide, dissolve the pellet immediately after it becomes clear. If the pellet dries out more, it will become very difficult to dissolve. To recover the RNA stored in formamide, add NaCl to a final concentration of 0.2 M, add 4 volumes of 100% ethanol, incubate 5 minutes at room temperature, then spin for 5 minutes at 10,000´g at 4°C in a microfuge. Rinse the pellet with 70% ethanol, spin 5 minutes at 7500´g at 4°C, and air dry pellet. When dry, dissolve in nuclease free water.

 

19.  Take a small aliquot of the RNA solution for measurement by UV spectrophotometry (typically a 1 in 25 or 1 in 50 dilution in 1´TNE). Make sure that the 260/280 ratio is at least 1.7 (high quality RNA gives a ratio of 2.0) otherwise the concentration readings will not be accurate. Re-extract the RNA if the ratio is below 1.7.

 

20.  Calculate the amount required to run 100ng on a standard 1% formamide agarose gel. For 100 ml gel volumes, add 1 g of agarose to 87 ml of depc-treated water and boil until dissolved. Cool to 60°C, then add 10 ml of 10´MOPS and 1.6 ml of formaldehyde, mix well, and pour into casting tray. Use 1´MOPS as the running buffer. Mix the RNA with water and 2.0 ul of RNA loading buffer (Sigma, R4268) so that the total volume is 8 ml, then heat the sample to 65°C for 10 minutes. The RNA loading buffer contains ethidium bromide, so use caution when handling this solution. Transfer the sample to ice for 5 minutes then load into the gel. It is also useful to include a size marker (Promega, G3191) for size comparisons. Run until the loading dyes have separated well, then photograph using UV illumination source. The RNA should give sharp 28S (~4.7 kb) and 18S (~1.86 kb) ribosomal bands, with the 28S band appearing denser. The 5S band should also be visible, and with very good quality RNA, should appear as two bands (tRNA and 5S ribosomal RNA). Note that samples dissolved in formamide will migrate at a slightly slower rate than the samples dissolved in water.


相关文章

破译水稻“沉默密码”挖掘育种新潜力

近日,中国农业科学院作物科学研究所野生稻保护与利用创新研究组联合国内外科研团队系统解析了水稻长链非编码RNA的多组学特征与表型效应,揭示了其驱动表型变异与育种潜力。相关研究成果发表在《细胞研究》(Ce......

基于深度学习的RNA多类型修饰解析算法

中国科学院动物研究所研究员赵方庆团队开发基于纳米孔RNA直接测序技术与深度学习策略的RNA修饰图谱解析算法ORCA。相关研究发表于《自然-通讯》。基于深度学习的RNA修饰系统识别与注释模型 ......

“重现”原始地球RNA自然合成之路

现代生命离不开三样东西:DNA、蛋白质和RNA。但问题是,它们不可能同时出现。蛋白质就像建筑工人和建筑材料,没有蛋白质,DNA无法复制;DNA就像建筑蓝图,没有DNA,蛋白质无法构建。为了解开这个“先......

化学家首次实现RNA与氨基酸连接

据27日《自然》杂志报道,英国伦敦大学学院(UCL)化学家通过模拟早期地球的条件,首次实现了RNA与氨基酸的化学连接。这一难题自20世纪70年代以来一直困扰着科学家,如今,这一突破性成果为解答生命起源......

新活检方法用RNA识别早期癌症

美国芝加哥大学团队开发了一种更为灵敏的液体活检技术,该方法利用RNA而不是传统的DNA来检测癌症。这一创新方法在使用患者血液样本进行测试时,识别出早期结直肠癌的准确率达到95%,显著优于现有的非侵入性......

重大突破!新加坡发布长读长RNA测序数据集SGNEx

由新加坡科技研究局基因组研究所领导的科学家团队,发布了迄今全球最大、最全面的长读长RNA测序数据集之一——新加坡纳米孔表达数据集(SG-NEx)。这一成果有望解决疾病研究中长期存在的技术瓶颈,使研究人......

RNA技术研发与产业化项目获大学生创业基金资助

4月15日,中国工程院院士、中国科学院亚热带农业生态研究所首席研究员印遇龙领衔的单胃动物营养研究团队在科技合作和成果转化上取得新进展。其团队博士生王芳以“RNA技术研发与产业化应用”为主的项目,历经初......

学者开发MIRROR提高RNA编辑效率

近日,中山大学生命科学学院教授张锐团队首次提出名为MIRROR的全新内源性ADAR招募gRNA设计理念,显著提高了RNA编辑效率,这一突破为RNA编辑技术走向临床应用注入了强劲动力,同时也为相关疾病的......

科研人员发展环形RNA适配体技术为治疗阿尔茨海默病提供新策略

中国科学院分子细胞科学卓越创新中心陈玲玲研究组揭示了双链RNA依赖的蛋白激酶R(PKR)在阿尔茨海默病(AD)发生与进展过程中异常激活的分子病理特征,开发了基于具有分子内短双链结构环形RNA(ds-c......

华山医院检验科:发现新型RNA靶点,探索抗癌新策略

在癌症治疗领域,化疗药物耐药性问题一直是阻碍治疗效果提升的关键瓶颈。癌细胞拥有多种复杂的机制,能够巧妙地逃避化疗药物的“攻击”,其中,高活性的抗氧化系统可以有效减轻药物诱导的活性氧(ROS)损伤,成为......